Irrespective of reaching an entire reaction with optimum induction therapy, minimum residual disorder typically persists, necessitating consolidation therapy to mitigate the risk of relapse by eradicating residual condition. In individuals which have acquired seven+three induction therapy, consolidation therapy is initiated with large-dose cytarab